People
The People Running This Company
Governance grade: D. WW filed Chapter 11 on May 6, 2025 and emerged June 24, 2025 with old common stock cancelled and converted 1-for-93 into new equity — a near-total wipeout for legacy shareholders. The pre-petition board and management collected three CEO transitions, an $8.9M Sistani pay package the year the equity collapsed, and a $4.5M cash retention award to CEO Tara Comonte two months before the filing. Comonte has since departed, leaving an Office-of-the-CEO under the CFO and COO while a permanent successor is sought. The post-emergence board is now dominated by restructuring veterans installed by the creditors who took the equity.
1. The People Running This Company
There is no permanent CEO. Day-to-day leadership runs through an "Office of the CEO" — CFO Felicia DellaFortuna and COO Jon Volkmann — with a board-level Transition Committee overseeing the search. The board itself was almost entirely replaced through the Chapter 11 plan: of the seven directors named in the April 2025 proxy, only Julie Bornstein remains a director today.
The CEO chair is empty for the third time in three years. Mindy Grossman → Sima Sistani (Mar 2022) → Comonte interim (Sept 2024) → Comonte permanent (Feb 2025) → Office of the CEO (early 2026). The pattern is a board that has not been able to retain or develop a CEO across the GLP-1 disruption.
2. What They Get Paid
Pay was decoupled from performance well before the Chapter 11. Sistani's reported 2023 compensation was $8.9M while the stock fell more than 80%; her compensation actually paid under the SEC's pay-versus-performance rule was $12.5M that same year. The Compensation Committee then amended its own 2024 bonus plan mid-year — lowering the subscription-revenue gate from $822.7M to $775.0M and removing the Clinical gatekeepers — and excluded $315M of impairments from the operating-income target, paying a 65% bonus on a reported $236M operating loss.
Pay sized like a healthy company. Comonte's 2025 architecture totals roughly $6.8M of cash (annualised salary plus retention plus interim bonus), structured to vest before any Chapter 11 outcome was known and protected by repayment provisions only if she resigned for the wrong reason. The $4.5M retention was approved February 26, 2025 — about 10 weeks before the May 6 bankruptcy filing — and explicitly replaced any 2025 bonus or equity grant. That is a cash bridge through restructuring, not pay-for-performance.
3. Are They Aligned?
Skin in the game was nominal before the Chapter 11 and was effectively erased through it. The April 2025 proxy reported all directors and executive officers as a group held 1.11% of the common stock (about 890,000 shares of 80.2M outstanding). On the June 24, 2025 effective date, every share was cancelled and reissued at 1 new share for every 93 old shares — Director Altschuler's 68,399 shares became 735, Director Shrank's 20,795 became 225, Director Brown's 30,655 became 329. Comonte's 400,710 share position became 4,304.
The post-emergence picture is dominated by option grants to insiders under a new Management Incentive Plan and a single conviction trade: Director Carney Hawks bought 29,057 new shares for $643,464 in the open market on November 19, 2025 — the lone meaningful cash purchase by an insider in the new equity. Hawks is co-founder of Brigade Capital Management, a credit hedge fund that almost certainly converted from creditor to equity-holder through the plan; his personal buy at $22.14 (the stock now trades around $9.84) is the strongest alignment signal in the file but should be read as a credit-fund principal averaging in, not as broad insider conviction.
Related-party legacy: the Oprah Winfrey arrangement
The proxy still details legacy related-party economics that defined WW for a decade:
- 6,362,103 shares sold to Oprah Winfrey in 2015 at $43.2M aggregate; she resigned from the board in 2024 and donated her remaining shares to the National Museum of African American History and Culture before bankruptcy.
- 3.5M-share option at $6.97 and a separate 3.28M-share option at $38.84 granted to Winfrey in connection with her endorsement deal — both with carve-outs in the change-of-control definition that disenfranchised other shareholders relative to her economics.
- Strategic Collaboration Agreement ran through May 31, 2025 — meaning the company paid for, and committed equity to, a brand asset that was rolling off the same week creditors were finalising the prepackaged plan.
- Artal/Invus — the LBO sponsor that held the company since 1999 — exited completely in 2023, taking the largest informed insider off the cap table well before the bankruptcy.
Capital allocation behaviour also failed alignment. The 2024 annual equity awards were granted on a fixed share price of $9.13 rather than the market price of roughly $1.89, multiplying issued share count vs. methodology by roughly 5x — a quiet way to deliver more dilution at the bottom while telling shareholders the dollar grant value was unchanged. Total fiscal 2024 reported operating loss was $236M; the Comp Committee adjusted it to a $91M adjusted operating income by excluding $315M of impairments, then paid 65% bonuses.
Skin-in-the-Game Score (Pre-Ch11)
Out of
Score: 2/10 (pre-emergence). Insiders held barely 1% of the equity, lost essentially all of it in the wipeout, but collected severance, retention, and accelerated cash anyway. Sistani walked away with $3.5M of 2024 cash plus prior-year stock; Comonte was bridged with $4.5M cash 10 weeks before filing; mid-year goalpost shifts produced 65%-of-target bonuses against a $236M operating loss. Hawks's $643K open-market buy is the only credible cash-on-the-line signal in the post-emergence file, and he represents a creditor-turned-shareholder, not classic insider conviction.
4. Board Quality
The pre-petition board is gone. The post-emergence board is a creditor-appointed restructuring board: Eugene I. Davis is one of the most prolific post-Ch11 independent directors in the United States; Carney Hawks brings the dominant credit-fund creditor's perspective; Sue E. Gove is fresh from running Bed Bath & Beyond's own Chapter 11; Lisa Gavales has a career in distressed retail. Bornstein is the lone bridge from the old board.
The new board is materially stronger on the work that needs to be done right now (capital structure, restructuring discipline, distressed retail) and weaker on the work the company also needs (clinical / GLP-1 strategy, brand). It is also visibly under-built — only Compensation, Audit, and NCG committees are publicly assigned for the new directors so far, with several seats marked "TBD." PwC remains auditor. Audit fees fell to $2.94M in FY2024 from $3.66M in FY2023 — modest decline despite the financial complexity that produced the bankruptcy.
One legitimate compliance lapse stood out before bankruptcy: the 2024 bonus plan was modified mid-year to lower targets, and a $315M impairment was excluded from the goal — both technically permitted, both undermining the link between pay and shareholder outcomes. The new Compensation Committee (Bornstein, Gavales) inherits a comp framework that needs to be rebuilt.
5. The Verdict
Governance Grade
Trajectory
The strongest positives. The Chapter 11 reset replaced the entire board with a credible restructuring slate. Carney Hawks's $643K open-market purchase is a real cash signal. The new Office-of-the-CEO structure under DellaFortuna and Volkmann is operationally credible while a permanent CEO is sought, and the board has explicitly contracted an external search firm rather than installing a creditor-friendly placeholder. PwC remains in place as auditor and the audit committee is now chaired by Sue Gove with operating-CEO experience.
The real concerns. Three CEO transitions in three years; an empty CEO seat today; pay routinely set ahead of performance and propped up with mid-year goalpost moves; a $4.5M cash retention to Comonte 10 weeks before bankruptcy; a fresh Management Incentive Plan being granted to executives whose old equity just zeroed; and a board still being filled (committees marked "TBD"). The Winfrey-era related-party economics are gone, but the discipline that allowed them is not yet proven to be replaced.
What would upgrade the grade. A permanent CEO with a credible operator background and a meaningful personal equity purchase, paired with one full year of pay outcomes that actually track equity performance — that would move the file from D to B−. A second creditor-side board member matching Hawks's personal cash purchase would reinforce the signal.
What would downgrade. Another mid-cycle modification of compensation targets, a "permanent" CEO appointment that turns out to be another bridge, or any related-party transaction with the new equity holders that would suggest the creditor-installed board is acting as a captive of its sponsors rather than as a fiduciary for all shareholders of the new common.